Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Selecta Biosciences Inc.

Latest From Sync-Rx Ltd.

Volcano: Learning To Thrive In A Declining PCI Market

Long used to a growing market driven by favorable demographics, cardiovascular companies are facing a declining PCI market, in the US and Europe at least, and are forced to shift their strategies to adapt. Volcano, for one, is articulating a new way to approach this declining market.

Medical Device Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Immune Disorders
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Selecta Biosciences Inc.
  • Senior Management
  • Werner Cautreels, PhD, Pres. & CEO
    David Siewers, CFO
    Lloyd Johnston, PhD, SVP, R&D & COO
    Peter Keller, CBO
    Takashi Kei Kishimoto, PhD, CSO
  • Contact Info
  • Selecta Biosciences Inc.
    Phone: (617) 923-1400
    480 Arsenal Way
    Watertown, MA 02472